Celularity (CELU) Cost of Revenue (2020 - 2025)

Celularity (CELU) has reported Cost of Revenue for 6 consecutive years, with $7.4 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cost of Revenue changed 0.42% year-over-year to $7.4 million; the TTM figure through Dec 2025 stood at $20.1 million (up 33.92% YoY), while the FY2025 annual figure was $20.1 million, up 33.92% from the prior year.
• Cost of Revenue climbed to $7.4 million in Q4 2025 per CELU's latest filing, from $3.9 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $10.7 million in Q4 2022 and bottomed at $258000.0 in Q4 2021.
• Historically, Cost of Revenue has averaged $3.3 million across 5 years, with a median of $2.1 million in 2023.
• Annual changes were most pronounced in 2022 — Cost of Revenue soared 4033.33% — and 2023, when it slumped 46.14%.
• Celularity's Cost of Revenue stood at $258000.0 in 2021, then jumped by 4033.33% to $10.7 million in 2022, then declined by 9.89% to $9.6 million in 2023, then slipped by 23.58% to $7.3 million in 2024, then rose by 0.42% to $7.4 million in 2025.
• Business Quant data shows CELU's Cost of Revenue at $7.4 million in Q4 2025, $3.9 million in Q3 2025, and $5.2 million in Q2 2025.